Organovo Holdings, Inc. was a big mover last session, as the company saw its shares rise over 9% on the day. The upside was driven by the company’s announcment that its ExVive Human Kidney Tissue was generating strong customer response following its recent launch in September. This resulted in solid volume with far more shares changing hands than in a normal session. This reverses the recent trend for the company since Oct 11, as the stock is now down nearly 31%.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Organovo Holdings currently carries a Zacks Rank #3 (Hold).

ORGANOVO HLDGS Price

ORGANOVO HLDGS Price | ORGANOVO HLDGS Quote

A better-ranked stock in the same industry is Adocia S.A. (ADOCY Quick QuoteADOCY - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ONVO going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>